PCSK9-IN-22 (compound 29) is an orally active inhibitor of PCSK9 . PCSK9-IN-22 inhibits the interaction of the protein with LDLR in vivo.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > PCSK9
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.